Skip navigation

Collaborate on Standards in Terminology • Examine Evolving Regulations • Enhance Clinical Quality and Data Collection Strategies

December 3-4, 2018
  • New York City, NY

CBI’s Digital Therapeutics forum unites senior stakeholders developing groundbreaking treatments to collaborate and chart a path forward for broad adoption of next generation digital therapies. This year’s event provides the ideal platform to convene with industry thought leaders from across the digital health spectrum to address regulatory, clinical development, software, business and legal challenges to ensure cutting edge treatments become commonplace.

UNCOVER GROUNDBREAKING STRATEGIES FROM INDUSTRY DISRUPTORS:

  • Convene with peers to address industry standards and the scope of what falls under the digital therapeutics umbrella
  • Understand stakeholder investor requirements and develop strategies to forge collaborative partnerships
  • Explore what manufacturers and independent investors look for in new investments
  • Chart a course to develop digital therapeutics from identifying the right pathology to target through to operationalization and roll-out
  • Prepare for challenges in clinical validation and data integrity in digital therapeutics trials
  • Navigate the changing landscape of payer and patient approaches to digital therapeutics reimbursements and business models
PLUS! Customize your experience with dedicated tracks for both Biopharma and Software

With widespread adoption of digital devices, prescription digital therapeutics could potentially play an important role in future treatment models for a range of diseases with high unmet medical need.

President, Novartis Institutes for Biomedical Research

Digital Therapeutics

Collaborate on Standards in Terminology • Examine Evolving Regulations • Enhance Clinical Quality and Data Collection Strategies

CBI’s Digital Therapeutics forum unites senior stakeholders developing groundbreaking treatments to collaborate and chart a path forward for broad adoption of next generation digital therapies. This year’s event provides the ideal platform to convene with industry thought leaders from across the digital health spectrum to address regulatory, clinical development, software, business and legal challenges to ensure cutting edge treatments become commonplace.

UNCOVER GROUNDBREAKING STRATEGIES FROM INDUSTRY DISRUPTORS:

  • Convene with peers to address industry standards and the scope of what falls under the digital therapeutics umbrella
  • Understand stakeholder investor requirements and develop strategies to forge collaborative partnerships
  • Explore what manufacturers and independent investors look for in new investments
  • Chart a course to develop digital therapeutics from identifying the right pathology to target through to operationalization and roll-out
  • Prepare for challenges in clinical validation and data integrity in digital therapeutics trials
  • Navigate the changing landscape of payer and patient approaches to digital therapeutics reimbursements and business models
PLUS! Customize your experience with dedicated tracks for both Biopharma and Software

With widespread adoption of digital devices, prescription digital therapeutics could potentially play an important role in future treatment models for a range of diseases with high unmet medical need.

President, Novartis Institutes for Biomedical Research